BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dupouy S, Mourra N, Doan VK, Gompel A, Alifano M, Forgez P. The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers. Biochimie 2011;93:1369-78. [PMID: 21605619 DOI: 10.1016/j.biochi.2011.04.024] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Srivastava A, Rikhari D, Pradhan B, Bharadwaj KK, Gaballo A, Quarta A, Jena M, Srivastava S, Ragusa A. An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives. Applied Sciences 2022;12:8990. [DOI: 10.3390/app12188990] [Reference Citation Analysis]
2 Schindler L, Wohlfahrt K, Gluhacevic von Krüchten L, Prante O, Keller M, Maschauer S. Neurotensin analogs by fluoroglycosylation at Nω-carbamoylated arginines for PET imaging of NTS1-positive tumors. Sci Rep 2022;12:15028. [PMID: 36056076 DOI: 10.1038/s41598-022-19296-0] [Reference Citation Analysis]
3 Kołat D, Kałuzińska Ż, Bednarek AK, Płuciennik E. Prognostic significance of AP-2α/γ targets as cancer therapeutics. Sci Rep 2022;12:5497. [PMID: 35361846 DOI: 10.1038/s41598-022-09494-1] [Reference Citation Analysis]
4 Liu HM, Ma LL, Li C, Cao B, Jiang Y, Han L, Xu R, Lin J, Zhang D. The molecular mechanism of chronic stress affecting the occurrence and development of breast cancer and potential drug therapy. Transl Oncol 2022;15:101281. [PMID: 34875482 DOI: 10.1016/j.tranon.2021.101281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Agrahari AK, Bose P, Jaiswal MK, Rajkhowa S, Singh AS, Hotha S, Mishra N, Tiwari VK. Cu(I)-Catalyzed Click Chemistry in Glycoscience and Their Diverse Applications. Chem Rev 2021;121:7638-956. [PMID: 34165284 DOI: 10.1021/acs.chemrev.0c00920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 50] [Article Influence: 2.0] [Reference Citation Analysis]
6 Iyer MR, Kunos G. Therapeutic approaches targeting the neurotensin receptors. Expert Opin Ther Pat 2021;31:361-86. [PMID: 33393392 DOI: 10.1080/13543776.2021.1866539] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Christou N, Blondy S, David V, Verdier M, Lalloué F, Jauberteau MO, Mathonnet M, Perraud A. Neurotensin pathway in digestive cancers and clinical applications: an overview. Cell Death Dis 2020;11:1027. [PMID: 33268796 DOI: 10.1038/s41419-020-03245-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
8 Takahashi K, Ehata S, Miyauchi K, Morishita Y, Miyazawa K, Miyazono K. Neurotensin receptor 1 signaling promotes pancreatic cancer progression. Mol Oncol 2021;15:151-66. [PMID: 33034134 DOI: 10.1002/1878-0261.12815] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Li L, Weiss HL, Li J, Chen Z, Donato L, Evers BM. High plasma levels of pro-NT are associated with increased colon cancer risk. Endocr Relat Cancer 2020;27:641-6. [PMID: 33055301 DOI: 10.1530/ERC-20-0310] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Kan Yeung AW, Georgieva MG, Kirilov K, Balacheva AA, Peeva MI, Horbańczuk OK, Horbańczuk JO, Lucarini M, Durazzo A, Santini A, Souto EB, Pajpanova TI, Milella L, Atanasov AG, Tzvetkov NT. Neurotensins and their therapeutic potential: research field study. Future Med Chem 2020;12:1779-803. [PMID: 33032465 DOI: 10.4155/fmc-2020-0124] [Reference Citation Analysis]
11 Fanelli R, Chastel A, Previti S, Hindié E, Vimont D, Zanotti-fregonara P, Fernandez P, Garrigue P, Lamare F, Schollhammer R, Balasse L, Guillet B, Rémond E, Morgat C, Cavelier F. Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS 1 -Positive Tumors Imaging. Bioconjugate Chem 2020;31:2339-49. [DOI: 10.1021/acs.bioconjchem.0c00419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Dongiovanni P, Meroni M, Petta S, Longo M, Alisi A, Soardo G, Valenti L, Miele L, Grimaudo S, Pennisi G, Antonio G, Consonni D, Fargion S, Fracanzani AL. Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158765. [PMID: 32663609 DOI: 10.1016/j.bbalip.2020.158765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang M, Wang H, Niu CQ, Zhang T, Wu Z, Li Z. Tetrazine-TCO Ligation: A Potential Simple Approach to Improve Tumor Uptake through Enhanced Blood Circulation. Bioconjugate Chem 2020;31:1795-803. [DOI: 10.1021/acs.bioconjchem.0c00264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Nikolaou S, Qiu S, Fiorentino F, Simillis C, Rasheed S, Tekkis P, Kontovounisios C. The role of Neurotensin and its receptors in non-gastrointestinal cancers: a review. Cell Commun Signal 2020;18:68. [PMID: 32336282 DOI: 10.1186/s12964-020-00569-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
15 Zygulska AL, Furgala A, Kaszuba-Zwoińska J, Krzemieniecki K, Gil K. Changes in plasma levels of cholecystokinin, neurotensin, VIP and PYY in gastric and colorectal cancer - Preliminary results. Peptides 2019;122:170148. [PMID: 31541684 DOI: 10.1016/j.peptides.2019.170148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
16 Prignon A, Provost C, Alshoukr F, Wendum D, Couvelard A, Barbet J, Forgez P, Talbot JN, Gruaz-Guyon A. Preclinical Evaluation of 68Ga-DOTA-NT-20.3: A Promising PET Imaging Probe To Discriminate Human Pancreatic Ductal Adenocarcinoma from Pancreatitis. Mol Pharm 2019;16:2776-84. [PMID: 31013092 DOI: 10.1021/acs.molpharmaceut.9b00283] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
17 Umezu K, Yajima R, Hiradate Y, Yanai R, Numabe T, Hara K, Oikawa T, Tanemura K. Improvement in blastocyst quality by neurotensin signaling via its receptors in bovine spermatozoa during in vitro fertilization. J Reprod Dev 2019;65:147-53. [PMID: 30662011 DOI: 10.1262/jrd.2018-147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
18 Wu Z, Fournel L, Stadler N, Liu J, Boullier A, Hoyeau N, Fléjou JF, Duchatelle V, Djebrani-Oussedik N, Agopiantz M, Ségal-Bendirdjian E, Gompel A, Alifano M, Melander O, Trédaniel J, Forgez P. Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody. Cancer Lett 2019;444:147-61. [PMID: 30583074 DOI: 10.1016/j.canlet.2018.12.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
19 Zhao X, Ren Y, Cui N, Wang X, Cui Y. Identification of key microRNAs and their targets in exosomes of pancreatic cancer using bioinformatics analysis. Medicine (Baltimore) 2018;97:e12632. [PMID: 30278585 DOI: 10.1097/MD.0000000000012632] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
20 Gao L, Zhang L, Li S, Wei L, Luo B, He R, Xia S. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis. Pathology - Research and Practice 2018;214:732-49. [DOI: 10.1016/j.prp.2018.03.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
21 Ouyang Q, Zhou J, Yang W, Cui H, Xu M, Yi L. Oncogenic role of neurotensin and neurotensin receptors in various cancers. Clin Exp Pharmacol Physiol 2017;44:841-6. [PMID: 28556374 DOI: 10.1111/1440-1681.12787] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 6.3] [Reference Citation Analysis]
22 Hashi H, Nakamura Y, Ishii J, Kondo A. Modifying Expression Modes of Human Neurotensin Receptor Type 1 Alters Sensing Capabilities for Agonists in Yeast Signaling Biosensor. Biotechnol J 2018;13:1700522. [DOI: 10.1002/biot.201700522] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
23 Abbaci A, Talbot H, Saada S, Gachard N, Abraham J, Jaccard A, Bordessoule D, Fauchais AL, Naves T, Jauberteau MO. Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis. Oncogene 2018;37:756-67. [PMID: 29059151 DOI: 10.1038/onc.2017.365] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
24 Bird JL, Simpson R, Vllasaliu D, Goddard AD. Neurotensin receptor 1 facilitates intracellular and transepithelial delivery of macromolecules. European Journal of Pharmaceutics and Biopharmaceutics 2017;119:300-9. [DOI: 10.1016/j.ejpb.2017.06.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
25 Agopiantz M, Forgez P, Casse JM, Lacomme S, Charra-Brunaud C, Clerc-Urmès I, Morel O, Bonnet C, Guéant JL, Vignaud JM, Gompel A, Gauchotte G. Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome. Virchows Arch 2017;471:521-30. [PMID: 28836043 DOI: 10.1007/s00428-017-2215-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
26 Mucke HA. Patent highlights December 2016-January 2017. Pharm Pat Anal 2017;6:97-104. [PMID: 28485665 DOI: 10.4155/ppa-2017-0007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Kim JT, Weiss HL, Evers BM. Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells. Int J Oncol 2017;50:2200-6. [PMID: 28498396 DOI: 10.3892/ijo.2017.3990] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
28 Maschauer S, Einsiedel J, Reich D, Hübner H, Gmeiner P, Wester HJ, Prante O, Notni J. Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors. Pharmaceuticals (Basel) 2017;10:E29. [PMID: 28287433 DOI: 10.3390/ph10010029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
29 Nohata N, Goto Y, Gutkind JS. Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer. J Hum Genet 2017;62:87-96. [PMID: 27734836 DOI: 10.1038/jhg.2016.124] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
30 Kim JT, Li J, Song J, Lee EY, Weiss HL, Townsend CM Jr, Evers BM. Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells. Oncotarget 2015;6:26960-70. [PMID: 26298774 DOI: 10.18632/oncotarget.4745] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
31 Liu R, Wong W, Ijzerman AP. Human G protein-coupled receptor studies in Saccharomyces cerevisiae. Biochemical Pharmacology 2016;114:103-15. [DOI: 10.1016/j.bcp.2016.02.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
32 Callegari CC, Cavalli IJ, Lima RS, Jucoski TS, Torresan C, Urban CA, Kuroda F, Anselmi KF, Cavalli LR, Ribeiro EM. Copy number and expression analysis of FOSL1, GSTP1, NTSR1, FADD and CCND1 genes in primary breast tumors with axillary lymph node metastasis. Cancer Genetics 2016;209:331-9. [DOI: 10.1016/j.cancergen.2016.06.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
33 Maschauer S, Einsiedel J, Hübner H, Gmeiner P, Prante O. 18 F- and 68 Ga-Labeled Neurotensin Peptides for PET Imaging of Neurotensin Receptor 1. J Med Chem 2016;59:6480-92. [DOI: 10.1021/acs.jmedchem.6b00675] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
34 Bolivar JH, Muñoz-garcía JC, Castro-dopico T, Dijkman PM, Stansfeld PJ, Watts A. Interaction of lipids with the neurotensin receptor 1. Biochimica et Biophysica Acta (BBA) - Biomembranes 2016;1858:1278-87. [DOI: 10.1016/j.bbamem.2016.02.032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
35 Hou T, Shi L, Wang J, Wei L, Qu L, Zhang X, Liang X. Label-free cell phenotypic profiling and pathway deconvolution of neurotensin receptor-1. Pharmacological Research 2016;108:39-45. [DOI: 10.1016/j.phrs.2016.04.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
36 Schulz J, Rohracker M, Stiebler M, Goldschmidt J, Grosser OS, Osterkamp F, Pethe A, Reineke U, Smerling C, Amthauer H. Comparative Evaluation of the Biodistribution Profiles of a Series of Nonpeptidic Neurotensin Receptor-1 Antagonists Reveals a Promising Candidate for Theranostic Applications. J Nucl Med 2016;57:1120-3. [DOI: 10.2967/jnumed.115.170530] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
37 Tiwari VK, Mishra BB, Mishra KB, Mishra N, Singh AS, Chen X. Cu-Catalyzed Click Reaction in Carbohydrate Chemistry. Chem Rev 2016;116:3086-240. [PMID: 26796328 DOI: 10.1021/acs.chemrev.5b00408] [Cited by in Crossref: 429] [Cited by in F6Publishing: 438] [Article Influence: 71.5] [Reference Citation Analysis]
38 Na Y, Choi JW, Kasala D, Hong J, Oh E, Li Y, Jung SJ, Kim SW, Yun CO. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model. J Control Release 2015;220:766-82. [PMID: 26471393 DOI: 10.1016/j.jconrel.2015.10.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
39 Zhou Z, Xie J, Cai Y, Yang S, Chen Y, Wu H. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer. Diagn Pathol. 2015;10:128. [PMID: 26215716 DOI: 10.1186/s13000-015-0356-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
40 Deng H, Wang H, Wang M, Li Z, Wu Z. Synthesis and Evaluation of 64Cu-DOTA-NT-Cy5.5 as a Dual-Modality PET/Fluorescence Probe to Image Neurotensin Receptor-Positive Tumor. Mol Pharm 2015;12:3054-61. [PMID: 26162008 DOI: 10.1021/acs.molpharmaceut.5b00325] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
41 Ouyang Q, Chen G, Zhou J, Li L, Dong Z, Yang R, Xu L, Cui H, Xu M, Yi L. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p. Neuro Oncol 2016;18:216-26. [PMID: 26180082 DOI: 10.1093/neuonc/nov114] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
42 Maschauer S, Greff C, Einsiedel J, Ott J, Tripal P, Hübner H, Gmeiner P, Prante O. Improved radiosynthesis and preliminary in vivo evaluation of a 18F-labeled glycopeptide–peptoid hybrid for PET imaging of neurotensin receptor 2. Bioorganic & Medicinal Chemistry 2015;23:4026-33. [DOI: 10.1016/j.bmc.2015.01.053] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
43 Dupouy S, Doan VK, Wu Z, Mourra N, Liu J, De Wever O, Llorca FP, Cayre A, Kouchkar A, Gompel A, Forgez P. Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice. Oncotarget 2014;5:8235-51. [PMID: 25249538 DOI: 10.18632/oncotarget.1632] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
44 Younes M, Wu Z, Dupouy S, Lupo AM, Mourra N, Takahashi T, Fléjou JF, Trédaniel J, Régnard JF, Damotte D, Alifano M, Forgez P. Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib. Oncotarget 2014;5:8252-69. [PMID: 25249545 DOI: 10.18632/oncotarget.1633] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
45 Dong X, Bai X, Zhao J, Wang L, Wang Q, Li L. The actions of neurotensin in rat bladder detrusor contractility. Sci Rep 2015;5:11192. [PMID: 26053252 DOI: 10.1038/srep11192] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
46 Ayala-sarmiento AE, Martinez-fong D, Segovia J. The Internalization of Neurotensin by the Low-Affinity Neurotensin Receptors (NTSR2 and vNTSR2) Activates ERK 1/2 in Glioma Cells and Allows Neurotensin-Polyplex Transfection of tGAS1. Cell Mol Neurobiol 2015;35:785-95. [DOI: 10.1007/s10571-015-0172-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
47 Ouyang Q, Gong X, Xiao H, Zhou J, Xu M, Dai Y, Xu L, Feng H, Cui H, Yi L. Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients. Mol Cancer 2015;14:21. [PMID: 25644759 DOI: 10.1186/s12943-015-0290-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
48 Guo S, Yan F, Xu J, Bao Y, Zhu J, Wang X, Wu J, Li Y, Pu W, Liu Y, Jiang Z, Ma Y, Chen X, Xiong M, Jin L, Wang J. Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC). Clin Epigenetics 2015;7:3. [PMID: 25657825 DOI: 10.1186/s13148-014-0035-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
49 Hiradate Y, Inoue H, Kobayashi N, Shirakata Y, Suzuki Y, Gotoh A, Roh SG, Uchida T, Katoh K, Yoshida M, Sato E, Tanemura K. Neurotensin enhances sperm capacitation and acrosome reaction in mice. Biol Reprod 2014;91:53. [PMID: 25031361 DOI: 10.1095/biolreprod.113.112789] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
50 Wu Z, Li L, Liu S, Yakushijin F, Yakushijin K, Horne D, Conti PS, Li Z, Kandeel F, Shively JE. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor. J Nucl Med 2014;55:1178-84. [PMID: 24854793 DOI: 10.2967/jnumed.114.137489] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
51 Castillo-Rodríguez RA, Arango-Rodríguez ML, Escobedo L, Hernandez-Baltazar D, Gompel A, Forgez P, Martínez-Fong D. Suicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice. PLoS One 2014;9:e97151. [PMID: 24824754 DOI: 10.1371/journal.pone.0097151] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
52 Maschauer S, Ruckdeschel T, Tripal P, Haubner R, Einsiedel J, Hübner H, Gmeiner P, Kuwert T, Prante O. In vivo monitoring of the antiangiogenic effect of neurotensin receptor-mediated radiotherapy by small-animal positron emission tomography: a pilot study. Pharmaceuticals (Basel) 2014;7:464-81. [PMID: 24743103 DOI: 10.3390/ph7040464] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
53 Moody TW, Chan DC, Mantey SA, Moreno P, Jensen RT. SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner. Life Sci 2014;100:25-34. [PMID: 24496038 DOI: 10.1016/j.lfs.2014.01.072] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
54 Ishii J, Oda A, Togawa S, Fukao A, Fujiwara T, Ogino C, Kondo A. Microbial fluorescence sensing for human neurotensin receptor type 1 using Gα-engineered yeast cells. Analytical Biochemistry 2014;446:37-43. [DOI: 10.1016/j.ab.2013.10.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
55 Zhang Y, Zhu S, Yi L, Liu Y, Cui H. Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells. Mol Cell Biochem 2014;389:1-8. [DOI: 10.1007/s11010-013-1920-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
56 Hernandez ME, Rembao JD, Hernandez-Baltazar D, Castillo-Rodriguez RA, Tellez-Lopez VM, Flores-Martinez YM, Orozco-Barrios CE, Rubio HA, Sánchez-García A, Ayala-Davila J, Arango-Rodriguez ML, Pavón L, Mejia-Castillo T, Forgez P, Martinez-Fong D. Safety of the intravenous administration of neurotensin-polyplex nanoparticles in BALB/c mice. Nanomedicine 2014;10:745-54. [PMID: 24333586 DOI: 10.1016/j.nano.2013.11.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
57 Lang C, Maschauer S, Hübner H, Gmeiner P, Prante O. Synthesis and evaluation of a (18)F-labeled diarylpyrazole glycoconjugate for the imaging of NTS1-positive tumors. J Med Chem 2013;56:9361-5. [PMID: 24160350 DOI: 10.1021/jm401491e] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
58 Morgat C, Hindié E, Mishra AK, Allard M, Fernandez P. Gallium-68: chemistry and radiolabeled peptides exploring different oncogenic pathways. Cancer Biother Radiopharm 2013;28:85-97. [PMID: 23461410 DOI: 10.1089/cbr.2012.1244] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
59 Falciani C, Brunetti J, Lelli B, Ravenni N, Lozzi L, Depau L, Scali S, Bernini A, Pini A, Bracci L. Cancer Selectivity of Tetrabranched Neurotensin Peptides Is Generated by Simultaneous Binding to Sulfated Glycosaminoglycans and Protein Receptors. J Med Chem 2013;56:5009-18. [DOI: 10.1021/jm400329p] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
60 Zhang JX, Wang K, Mao ZF, Fan X, Jiang DL, Chen M, Cui L, Sun K, Dang SC. Application of liposomes in drug development--focus on gastroenterological targets. Int J Nanomedicine. 2013;8:1325-1334. [PMID: 23630417 DOI: 10.2147/ijn.s42153] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
61 Wu Z, Martinez-Fong D, Trédaniel J, Forgez P. Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy. Front Endocrinol (Lausanne) 2012;3:184. [PMID: 23335914 DOI: 10.3389/fendo.2012.00184] [Cited by in Crossref: 29] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]
62 Oates J, Faust B, Attrill H, Harding P, Orwick M, Watts A. The role of cholesterol on the activity and stability of neurotensin receptor 1. Biochimica et Biophysica Acta (BBA) - Biomembranes 2012;1818:2228-33. [DOI: 10.1016/j.bbamem.2012.04.010] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
63 Müller KM, Tveteraas IH, Aasrum M, Ødegård J, Dawood M, Dajani O, Christoffersen T, Sandnes DL. Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells. BMC Cancer 2011;11:421. [PMID: 21961726 DOI: 10.1186/1471-2407-11-421] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]